The new study, published in the journal Nature, provides important insights into how cofilin works at the molecular level. The researchers found that cofilin binds to a specific site on actin filaments, which are the building blocks of the cellular skeleton. This binding prevents the actin filaments from polymerizing into larger structures, which leads to the disassembly of the cellular skeleton.
"Our findings provide a detailed understanding of how cofilin regulates the cellular skeleton," said study leader Dr. David Drubin, a professor of biochemistry and biophysics at UCSF. "This information could lead to new treatments for diseases that are associated with defects in the cellular skeleton."
The cellular skeleton is a dynamic structure that is constantly being assembled and disassembled. This process is essential for many cellular functions, including cell movement, cell division, and adhesion. Cofilin is one of the key proteins involved in regulating the assembly and disassembly of the cellular skeleton.
When the cell needs to disassemble its skeleton, cofilin is activated and binds to actin filaments. This binding prevents the actin filaments from polymerizing into larger structures, which leads to the disassembly of the cellular skeleton.
The researchers used X-ray crystallography to determine the structure of cofilin bound to actin filaments. This allowed them to see how cofilin interacts with actin at the molecular level. This information could lead to new treatments for diseases that are associated with defects in the cellular skeleton.
For example, cofilin is known to be involved in the development of several diseases, including cancer, Alzheimer's disease, and Parkinson's disease. By understanding how cofilin works at the molecular level, scientists may be able to develop new drugs that target cofilin and prevent these diseases from developing.
"Our findings provide a foundation for understanding how cofilin regulates the cellular skeleton," said Drubin. "This information could lead to new treatments for diseases that are associated with defects in the cellular skeleton."
